230 related articles for article (PubMed ID: 23401038)
1. Efficacy of a topical sesame/rose geranium oil compound in patients with hereditary hemorrhagic telangiectasia associated epistaxis.
Reh DD; Hur K; Merlo CA
Laryngoscope; 2013 Apr; 123(4):820-2. PubMed ID: 23401038
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of intranasal Bevacizumab (Avastin) treatment in patients with hereditary hemorrhagic telangiectasia-associated epistaxis.
Karnezis TT; Davidson TM
Laryngoscope; 2011 Mar; 121(3):636-8. PubMed ID: 21344445
[TBL] [Abstract][Full Text] [Related]
3. Antiestrogen therapy for hereditary hemorrhagic telangiectasia: a double-blind placebo-controlled clinical trial.
Yaniv E; Preis M; Hadar T; Shvero J; Haddad M
Laryngoscope; 2009 Feb; 119(2):284-8. PubMed ID: 19160429
[TBL] [Abstract][Full Text] [Related]
4. Sclerotherapy and Topical Nasal Propranolol: An Effective and Safe Therapy for HHT-Epistaxis.
Esteban-Casado S; Martín de Rosales Cabrera AM; Usarralde Pérez A; Martínez Simón JJ; Zhan Zhou E; Marcos Salazar MS; Pérez Encinas M; Botella Cubells L
Laryngoscope; 2019 Oct; 129(10):2216-2223. PubMed ID: 30908653
[TBL] [Abstract][Full Text] [Related]
5. A new endoscopic staging system for hereditary hemorrhagic telangiectasia.
Reh DD; Yin LX; Laaeq K; Merlo CA
Int Forum Allergy Rhinol; 2014 Aug; 4(8):635-9. PubMed ID: 24782401
[TBL] [Abstract][Full Text] [Related]
6. Percutaneous embolization on hereditary hemorrhagic telangiectasia patients with severe epistaxis.
Braak SJ; de Witt CA; Disch FJ; Overtoom TT; Westermann JJ
Rhinology; 2009 Jun; 47(2):166-71. PubMed ID: 19593974
[TBL] [Abstract][Full Text] [Related]
7. Bevacizumab in hereditary hemorrhagic telangiectasia-associated epistaxis: effectiveness of an injection protocol based on the vascular anatomy of the nose.
Dheyauldeen S; Østertun Geirdal A; Osnes T; Vartdal LS; Dollner R
Laryngoscope; 2012 Jun; 122(6):1210-4. PubMed ID: 22565282
[TBL] [Abstract][Full Text] [Related]
8. Effect of Topical Intranasal Therapy on Epistaxis Frequency in Patients With Hereditary Hemorrhagic Telangiectasia: A Randomized Clinical Trial.
Whitehead KJ; Sautter NB; McWilliams JP; Chakinala MM; Merlo CA; Johnson MH; James M; Everett EM; Clancy MS; Faughnan ME; Oh SP; Olitsky SE; Pyeritz RE; Gossage JR
JAMA; 2016 Sep; 316(9):943-51. PubMed ID: 27599329
[TBL] [Abstract][Full Text] [Related]
9. Treatment of hereditary hemorrhagic telangiectasia with submucosal and topical bevacizumab therapy.
Karnezis TT; Davidson TM
Laryngoscope; 2012 Mar; 122(3):495-7. PubMed ID: 22147664
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of Timolol in a Novel Intranasal Thermosensitive Gel for Hereditary Hemorrhagic Telangiectasia-Associated Epistaxis: A Randomized Clinical Trial.
Peterson AM; Lee JJ; Kallogjeri D; Schneider JS; Chakinala MM; Piccirillo JF
JAMA Otolaryngol Head Neck Surg; 2020 Nov; 146(11):1006-1014. PubMed ID: 32940653
[TBL] [Abstract][Full Text] [Related]
11. Intranasal topical estrogen in the management of epistaxis in hereditary hemorrhagic telangiectasia.
Minami K; Haji T
Acta Otolaryngol; 2016; 136(5):528-31. PubMed ID: 26808464
[TBL] [Abstract][Full Text] [Related]
12. Epistaxis in children and adolescents with hereditary hemorrhagic telangiectasia.
Gonzalez CD; Mcdonald J; Stevenson DA; Whitehead KJ; Petersen MG; Presson AP; Ding Q; Wilson KF
Laryngoscope; 2018 Jul; 128(7):1714-1719. PubMed ID: 29171658
[TBL] [Abstract][Full Text] [Related]
13. The minimal important difference of the epistaxis severity score in hereditary hemorrhagic telangiectasia.
Yin LX; Reh DD; Hoag JB; Mitchell SE; Mathai SC; Robinson GM; Merlo CA
Laryngoscope; 2016 May; 126(5):1029-32. PubMed ID: 26393959
[TBL] [Abstract][Full Text] [Related]
14. Topical propranolol improves epistaxis in patients with hereditary hemorrhagic telangiectasia - a preliminary report.
Mei-Zahav M; Blau H; Bruckheimer E; Zur E; Goldschmidt N
J Otolaryngol Head Neck Surg; 2017 Oct; 46(1):58. PubMed ID: 28978360
[TBL] [Abstract][Full Text] [Related]
15. [Argon plasma coagulation and topically applied estriol. Long-term results in the treatment of hereditary hemorrhagic telangiectasia of the nasal mucosa].
Sadick H; Riedel F; Oulmi J; Hörmann K; Bergler WF
HNO; 2003 Feb; 51(2):118-24. PubMed ID: 12589417
[TBL] [Abstract][Full Text] [Related]
16. A silicone nasal swab for the treatment of severe and recalcitrant epistaxis in hereditary hemorrhagic telangiectasia: an alternative to surgical nostril closure.
Bruschini L; Seccia V; Dallan I
Am J Otolaryngol; 2011; 32(4):301-3. PubMed ID: 20719406
[TBL] [Abstract][Full Text] [Related]
17. The SF-36 health status questionnaire in assessing patients with epistaxis secondary to hereditary hemorrhagic telangiectasia.
Lennox PA; Hitchings AE; Lund VJ; Howard DJ
Am J Rhinol; 2005; 19(1):71-4. PubMed ID: 15794078
[TBL] [Abstract][Full Text] [Related]
18. Anti-estrogen therapy for hereditary hemorrhagic telangiectasia - a long-term clinical trial.
Yaniv E; Preis M; Shevro J; Nageris B; Hadar T
Rhinology; 2011 Jun; 49(2):214-6. PubMed ID: 21743879
[TBL] [Abstract][Full Text] [Related]
19. Prospective randomized trial of sclerotherapy vs standard treatment for epistaxis due to hereditary hemorrhagic telangiectasia.
Boyer H; Fernandes P; Le C; Yueh B
Int Forum Allergy Rhinol; 2015 May; 5(5):435-40. PubMed ID: 25643928
[TBL] [Abstract][Full Text] [Related]
20. Cauterization for epistaxis in hereditary hemorrhagic telangiectasia.
Dabiri J; Fakhoury R; Choufani G; Mine B; Hassid S
B-ENT; 2016; 12(1):9-16. PubMed ID: 27097388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]